Share Name Share Symbol Market Type Share ISIN Share Description
Iofina Plc LSE:IOF London Ordinary Share GB00B2QL5C79 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.375 -2.65% 13.75 254,631 14:00:06
Bid Price Offer Price High Price Low Price Open Price
13.50 14.00 14.125 13.725 14.125
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 29.69 1.28 0.70 19.6 26
Last Trade Time Trade Type Trade Size Trade Price Currency
16:27:46 O 352 13.9999 GBX

Iofina (IOF) Latest News

More Iofina News
Iofina Investors    Iofina Takeover Rumours

Iofina (IOF) Discussions and Chat

Iofina Forums and Chat

Date Time Title Posts
17/9/202112:03Iofina - US Iodine producer3,628
14/9/202109:49iofina iodine and Canabis oil11,041
17/6/202107:23Iofina recovery7,003
08/5/202108:49IOF tipsters2,654
16/4/202116:13Iofina Private Investors Meeting - Cheltenham175

Add a New Thread

Iofina (IOF) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-09-17 15:27:4614.0035249.28O
2021-09-17 13:21:4413.6650,0006,830.00O
2021-09-17 13:00:4713.9450,0006,968.75O
2021-09-17 13:00:0913.9420,0002,787.50O
2021-09-17 12:51:1613.7540055.00O
View all Iofina trades in real-time

Iofina (IOF) Top Chat Posts

Iofina Daily Update: Iofina Plc is listed in the General Financial sector of the London Stock Exchange with ticker IOF. The last closing price for Iofina was 14.13p.
Iofina Plc has a 4 week average price of 11.38p and a 12 week average price of 11.38p.
The 1 year high share price is 15.38p while the 1 year low share price is currently 10.63p.
There are currently 191,858,408 shares in issue and the average daily traded volume is 545,708 shares. The market capitalisation of Iofina Plc is £26,380,531.10.
abid6814: Good to see some follow up momentum in price action and buyer interest after the two holding statements last week.With an update from the company due I really do hope they can supply the strategic and business operations catalyst for the share price to continue its upward movement.Will be the first financial update on revenue, profits and debt since, expecting decent news on all three fronts. The Achilles heel remains expansion plans and guarantee of supply so that production increases with each new plant rather than going into reverse as has been the tendency over the last year or so.Interestingly there seems to be a significant tick up in cannaboid stocks, MXC in particular has been good for me. Dare we dream of seed sales!
naphar: Newlands go from 5.64% total to 6.63% buying about 1.9m more shares. On the other hand, Richard Sneller goes from somewhere under 3% to 5.8% buying at least roughly 5.4m shares, quite a confidence show. Interesting, could we be about to see a rerate to a better share price I wonder?
muffinhead: Finncap morning report Iofina (IOF): Corp Record results, more to come Iofina has delivered record results in 2020, no mean feat given the severe direct and indirect challenges thrown up by the pandemic. It represents the fourth consecutive year of production, revenue and EBITDA growth, testament to management’s delivery of its turnaround strategy. With one of the lowest cost iodine production bases globally, a strong and diversified product portfolio, a significantly improved balance sheet and a strengthening iodine market, Iofina is well placed to be a major beneficiary of the global recovery from the pandemic.
ansana: AWOL, I agree with your comment. I guess because I simply dont know but with a jilted lover now turned aggressor stalking IOF undermining them at ever opportunity and perhaps actively working to hold down the share price it makes it difficult for Iof to proceed in a way many shareholders would like to see me included. Let's face it IOF have publicly recognised the threat so it has to be very serious and it may limit what they can do. Our finances are in a better place but we are still carrying debt. Again this is my opinion but when they managed to extricate themselves from Belize recognising it as a disaster at so many levels they attempted to pursue their CBD ambition with the seed initiative. If successful it could have led to other developments. They were cautious and they were operating at a time of ever changing legislation. One thing is key, yes they and we MAY end up loosing financially but they haven't destroyed the company. Belize would have destroyed the company as we know it. What are IOF doing now, what they have done for the last 10 years with and for our company, saved it, grown it, refinanced it got it back to a much stronger footing strong enough to withstand the jilted hulk and his cronies. I am genuinely optimistic for this year and next. Most importantly, iodine prices are on the up. All the time the share price is artificially held back the company is gaining in strength. We are building a slow steady head of steam which will propel us to our target price and beyond. At one time we all agonised over whether they had enough puff to keep going.
globalwill: RNS Number : 7706Q Iofina PLC 01 March 2021 Iofina plc ("Iofina" or the "Company") Director/PDMR Dealing Iofina plc (AIM: IOF) announces that it received notification on 1 March 2021 that Lance J Baller, Non-Executive Chairman of the Company, purchased 162,500 ordinary shares in the capital of the Company at a price of 12.75 pence per share. Further details are set out in the Notification of Dealing Form below.
severnof9: I would agree with the churn suggestion. It can be used to accumulate as happened on Blinkx/tremor or to serve a major shareholders purpose to unseat the present board. This is a profitable company and I am using the low share price to accumulate. This will play out eventually and the share price will reflect reality of future good newsflow and increasing profitability. I do think current management is too cautious with expansion but perhaps having lived through a tortured period of refinancing during Covid they dont want to take on too much debt at present.
madchick: I wish I'd known that questions would be closed at 9am (I'm assuming BST)! I'll have to post mine as soon as the presentation starts while they're doing the standard background stuff. I wanted to wait until the results in case some of my questions became redundant. Firstly, good set of results, particularly during a pandemic. For me, I'm clearer now on why the delay with IO9 (although I am getting a bit irritated at their continual claim to need to know more information first - information [eg oil prices/availability) isn't exactly stable so there's a risk of it taking forever. I'm happy for them to wait until they can get a good price for the seeds. Interesting that major shareholders have now been listed as a company risk. Not sure whether to ask the question about their relationship with AB now - from the results, it seems AB is still a risk. It would be nice to know if anything's going on behind the scenes, though! I'm also happy with the information about Iofina Chemical's improved performance, which (I hope) demonstrates the value of the new product. As usual, Iofina Chemical saves the day. It might indeed be wiser to invest more in that side of the business rather than in Iofina Resources. It's hard to remember that because our focus here is always so much on IR and not on IC. And if products are confidential, there's not much we can talk about, so I guess we naturally turn to IR. I'd been thinking about asking about IofinaEx but it seems that really is dormant. Interesting about the WET patents - only three more years to run (I think they said), but I think these have already been superseded by better technology and I understand that the chemical balance is key (rather than the patent itself). I think the fixed interest rate on the majority of the loan will turn out to be a huge blessing, given that inflation, and thus (I assume) interest rates, is set to rise post-pandemic. The risk there is maybe increased poverty and less demand for products, although lower demand may be mitigated by increased iodine price. I'm fully behind the diversification strategy. Healthcare uses will always be required, for instance. A great set of results though and it sounds like the current year is going well so far... I'm still missing a bit of a sense of ambition. Good to hear that they are going on an investor road show....
rheumking: I just can’t believe we are sitting on the share price of 11 with all the obstacles that were meant to be in the way cleared out – the debt , The new plant sorted and the iodine price soaring. For me there is a disconnect between the share price and the companies performance which could either be due to someone unloading a big position as there seem to be evidence of in today’s large whole number sales, Manipulation to try and bring about a change in the board , or worst of all just a complete lack of interest from the investing community. All a bit depressing and the longer I have been involved with the stock market more I realise it is far from a perfect pricing mechanism - or if it is there is usually a delay of several years.
activmojo: Call me old fashioned, I thought the share price is the best measure of progress or managements success. Just scroll up and look at the long term share price performance. Also you could look at the effect of the last two trading updates, 16thOct & 19th Jan and the share price reaction. If you hold and are content with the situation and the forward out look then thats fair enough I'm not content but at the moment don't see a way up from here. As the saying goes if you keep doing the same action don't expect a different outcome or something like that:)
blackprince_1: I have been buying at these prices as I know the BOD want the share price over the 16p placing price before AB shows his hand. Win win situation. AB plans will see the share price over 40p+ in old Iofina money over the three listings. The current BOD I hear will fight it with a potential partnership for faster growth.
Iofina share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210918 08:41:59